Back to Systemic Lupus Erythematosus

Research record changes

The latest 100 trial status and retraction changes detected since change tracking began. Dates show when RareWays recorded the change, which may be later than the source update. Earlier history is unavailable.

  1. Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune Diseases

    RECRUITING → WITHDRAWN

    Recorded 2026-10-15

    View record
  2. A Clinical Study of YTS109 Cell in R/R Systemic Lupus Erythematosus

    RECRUITING → TERMINATED

    Recorded 2026-10-14

    View record
  3. A Trial in Healthy Adult Participants and Adults With Autoimmune Disease to Test How HBM7020 is Tolerated and Absorbed in the Body

    NOT YET RECRUITING → RECRUITING

    Recorded 2026-10-14

    View record
  4. Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment

    NOT YET RECRUITING → RECRUITING

    Recorded 2026-10-02

    View record
  5. A Clinical Study to Evaluate LVIVO-TaVec400 for the Treatment of Relapsed/Refractory Autoimmune Diseases

    NOT YET RECRUITING → WITHDRAWN

    Recorded 2026-10-02

    View record
  6. Integration of Remote Monitoring in the Management of Chronic Immunosuppressive Therapy

    RECRUITING → UNKNOWN

    Recorded 2026-10-01

    View record
  7. Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseases

    RECRUITING → UNKNOWN

    Recorded 2026-10-01

    View record
  8. Early Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases

    RECRUITING → UNKNOWN

    Recorded 2026-10-01

    View record
  9. Anti-CD20 Antibodies for Treatment of SLE-PAH

    RECRUITING → UNKNOWN

    Recorded 2026-10-01

    View record
  10. Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases

    NOT YET RECRUITING → UNKNOWN

    Recorded 2026-10-01

    View record
  11. Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease

    RECRUITING → UNKNOWN

    Recorded 2026-10-01

    View record
  12. UCAR T-cell Therapy Targeting CD19/ BCMA(QT-019C) in Patients With Relapse/ Refractory Autoimmune Diseases

    NOT YET RECRUITING → WITHDRAWN

    Recorded 2026-10-01

    View record
  13. ILD-SARDs Registry and Biorepository

    RECRUITING → UNKNOWN

    Recorded 2026-10-01

    View record
  14. Anti-CD19-CD3E-CAR-T Cells in Relapsed/Refractory Autoimmune Disease

    RECRUITING → UNKNOWN

    Recorded 2026-10-01

    View record
  15. An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease

    RECRUITING → UNKNOWN

    Recorded 2026-10-01

    View record
  16. Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

    RECRUITING → UNKNOWN

    Recorded 2026-10-01

    View record